當前位置:BPS Bioscience Inc.>>CAR T-Cell Therapy Cell Lines>> 78769NY-ESO-1 TCR (1G4) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line
參 考 價 | 面議 |
產品型號78769
品 牌BPS Bioscience
廠商性質生產商
所 在 地
更新時間:2024-11-26 16:02:47瀏覽次數(shù):161次
聯(lián)系我時,請告知來自 化工儀器網(wǎng)Anti-BCMA CAR /NFAT (Luciferase) Re
Anti-CD19 CAR / NFAT (Luciferase) R
This cell line was generated from T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (BPS Bioscience #78556) by overexpression of human CD8 (NM_001768.6) and NY-ESO-1 TCR (1G4) using lentiviral transduction (CD8a Lentivirus #78648 and NY-ESO-1 -Specific TCR Lentivirus Clone 1G4 #78675). The human TCR clone 1G4 specifically recognizes antigen NY-ESO-1 (New York esophageal squamous cell carcinoma 1).
Figure 1: Illustration of the functional co-culture assay used to validate the NY-ESO-1 TCR (1G4) CD8+ NFAT-Luciferase Reporter Jurkat cell line.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供,信息內容的真實性、準確性和合法性由相關企業(yè)負責,化工儀器網(wǎng)對此不承擔任何保證責任。
溫馨提示:為規(guī)避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。